 |
 |
Hello! I learned a ton from your dissection of "the list" -- thank you! I would like to share the information you provided with some other people but I must have deleted it from my computer. Could you, would you re-send it? Sorry for the trouble. Holly On Feb 25, 2007, at 10:04 AM, rayilynlee wrote: > Results so far have been encouraging. Twelve patients who received the > surgery in Phase I trials at the University of California-San > Francisco and > Rush University Medical Center in Chicago reported a 40 percent > improvement > in their motor skills. > Side effects included mild to moderate temporary dyskinesia, or > involuntary > movement. This was treated successfully by readjusting the dosage of > traditional Parkinson's medications, Boulis said. > Another advantage of CERE-120: "You don't have a wire and battery > in your > body," Boulis said, referring to equipment left over from deep-brain > stimulation, another Parkinson's treatment. > Fifty-one participants nationwide are being sought for the trial's > second > phase, and enrollment is still open. Seventeen patients will be > part of a > control group and not receive CERE-120 initially. > In addition to the work in Cleveland, San Francisco and Chicago, > trials are > taking place in Birmingham, Ala.; New York; Durham, N.C.; Portland, > Ore.; > Houston; and Philadelphia. > "We've got to try every avenue there is, and we've got to try them on > people," Brandt said. "Everybody's hoping one of them will break > through." > To be eligible for the trial, participants must be 35 to 75 years > old, have > had the disease for five years and have pursued dissimilar treatments > without success. Exclusionary factors include atypical forms of the > disease, > chemotherapy, history of drug or alcohol abuse and the presence of > medical > conditions that could complicate surgery. > The Michael J. Fox Foundation says it has contributed more than > $2.6 million > in support of the trials. > To reach this Plain Dealer reporter: > [log in to unmask], 216-999-3906 > Previous | 1 | 2 > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn William Angus [log in to unmask] ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn